Bioequivalence Assessment of an Oral Fixed-Dose Formulation of Dutasteride-Tamsulosin 0.5 mg/0.4 mg: A Randomized, Single-Blind, Single-Dose, 2-Period Crossover Study in Mexican Population Under Fasted Conditions.
Saved in:
| Title: | Bioequivalence Assessment of an Oral Fixed-Dose Formulation of Dutasteride-Tamsulosin 0.5 mg/0.4 mg: A Randomized, Single-Blind, Single-Dose, 2-Period Crossover Study in Mexican Population Under Fasted Conditions. |
|---|---|
| Authors: | Piñeyro-Garza E; Ipharma, S.A. de C.V., Colonia Mitras Centro, Monterrey, Nuevo León, México., Gómez-Silva M; Ipharma, S.A. de C.V., Colonia Mitras Centro, Monterrey, Nuevo León, México., Gamino ME; Ipharma, S.A. de C.V., Colonia Mitras Centro, Monterrey, Nuevo León, México., Delgado-Roche L; Laboratorios Liomont, S.A. de C.V., Colonia Cuajimalpa, Cuajimalpa de Morelos, Ciudad de México, México. |
| Source: | Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2022 Mar; Vol. 11 (3), pp. 318-323. Date of Electronic Publication: 2021 Aug 12. |
| Publication Type: | Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2160-7648 (Electronic) Linking ISSN: 2160763X NLM ISO Abbreviation: Clin Pharmacol Drug Dev Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2160-7648 |
|---|---|
| DOI: | 10.1002/cpdd.1011 |
